Get the Stockscreener App
4.03
4.95%
-0.21
Vanda Pharmaceuticals Inc Stock (VNDA) Forecast
The Vanda Pharmaceuticals Inc (VNDA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.6212, representing a +14.67% increase from the current price of $4.03. The highest analyst price target is $7.2155, and the lowest is $2.0269.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VNDA Price Target
Average 3.663
(-9.11% Downside)
Is Vanda Pharmaceuticals Inc (VNDA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.38 | Buy |
| STOCH(9,6) | 16.13 | Buy |
| STOCHRSI(14) | 5.1499 | Buy |
| MACD(12,26) | -0.2577 | Sell |
| ADX(14) | 36.51 | Sell |
| William %R | -97.07 | Buy |
| CCI(14) | -93.61 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.409
Sell
|
4.3972
Sell
|
| MA20 |
4.7038
Sell
|
4.6145
Sell
|
| MA50 |
5.0291
Sell
|
4.9764
Sell
|
| MA100 |
5.4311
Sell
|
5.3869
Sell
|
| MA200 |
6.4076
Sell
|
5.6014
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VNDA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on VNDA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.38 indicates that VNDA is oversold. This indicates that VNDA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 16.13 indicates that VNDA is oversold. This indicates that VNDA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.1499 indicates that VNDA is oversold. This suggests that VNDA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.51 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -93.61 indicates that VNDA is still oversold but not to an extreme extent.
Long-term VNDA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vanda Pharmaceuticals Inc financial reports and earnings history, Vanda Pharmaceuticals Inc (VNDA) stock could reach $2.6833 by 2030, $25.08 by 2040 and $55.08 by 2050. See the projected annual prices until 2050 of the Vanda Pharmaceuticals Inc stock below:
- Vanda Pharmaceuticals Inc (VNDA) is expected to reach an average price of $14.08 in 2035, with a high prediction of $14.68 and a low estimate of $14.70. This indicates an $249.33% rise from the last recorded price of $4.03.
- Vanda Pharmaceuticals Inc (VNDA) stock is projected to chart a bullish course in 2040, with an average price target of $24.68, representing an $512.52% surge from its current level. The forecast ranges from a conservative $25.14 to a sky-high $25.08.
- Our analysts predict Vanda Pharmaceuticals Inc (VNDA) to jump 885.42% by 2045, soaring from $36.53 to an average price of $39.71, potentially reaching $36.60. While $36.53 is the low estimate, the potential upside is significant.
- Vanda Pharmaceuticals Inc (VNDA) stock is expected to climb by 2050, reaching an average of $54.66, a $1,256% jump from its current level. However, a wide range of estimates exists, with high and low targets of $55.08 and $55.40, respectively, highlighting the market's uncertainty.
Vanda Pharmaceuticals Inc Stock (VNDA) Year by Year Forecast
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2026
The predicted value for Vanda Pharmaceuticals Inc (VNDA) in 2026 is set at an average of $5.7513. Estimates vary from a peak of $9.94 to a trough of $1.5625, indicating an +42.71% surge from the present price of $4.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.1269 | $2.0269 | $7.2155 | -47.22% |
| December, 2026 | $4.0582 | $1.5625 | $4.0782 | +0.70% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vanda Pharmaceuticals Inc (VNDA) is $2.0733, with a high forecast of $4.036 and a low forecast of $0.1106. This indicates an -48.55% decrease from the last price of $4.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4194 | $0.1106 | $4.036 | -89.59% |
| February, 2027 | $0.0993 | $0.1773 | $1.5529 | -97.54% |
| March, 2027 | $2.2902 | $0.3415 | $1.9858 | -43.17% |
| April, 2027 | $1.4489 | $1.9589 | $1.4289 | -64.05% |
| May, 2027 | $3.4899 | $1.8211 | $2.7199 | -13.40% |
| June, 2027 | $3.1086 | $3.1886 | $2.8842 | -22.86% |
| July, 2027 | $2.0873 | $3.0873 | $3.0851 | -48.21% |
| August, 2027 | $1.6282 | $1.5639 | $1.7995 | -59.60% |
| September, 2027 | $2.097 | $1.9704 | $1.897 | -47.97% |
| October, 2027 | $2.0057 | $1.9835 | $1.8557 | -50.23% |
| November, 2027 | $2.2966 | $2.3451 | $2.2001 | -43.01% |
| December, 2027 | $1.4253 | $1.6832 | $1.5989 | -64.63% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2028
In 2028, Vanda Pharmaceuticals Inc (VNDA) is projected to reach an average price of $3.2886, with a high projection of $5.2289 and a low estimate of $1.3484. This indicates an -18.40% fall from the last price of $4.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8563 | $1.4963 | $1.0719 | -78.75% |
| February, 2028 | $4.225 | $1.3484 | $4.3028 | +4.84% |
| March, 2028 | $3.8137 | $4.0037 | $4.0072 | -5.37% |
| April, 2028 | $4.2525 | $3.8181 | $3.9725 | +5.52% |
| May, 2028 | $4.6034 | $4.8168 | $4.6812 | +14.23% |
| June, 2028 | $4.5121 | $4.3949 | $4.2356 | +11.96% |
| July, 2028 | $4.583 | $4.7158 | $4.5265 | +13.72% |
| August, 2028 | $4.1317 | $4.7167 | $4.5896 | +2.52% |
| September, 2028 | $3.9505 | $4.1805 | $3.9939 | -1.97% |
| October, 2028 | $4.4314 | $4.4513 | $4.3592 | +9.96% |
| November, 2028 | $4.9501 | $4.4658 | $4.5101 | +22.83% |
| December, 2028 | $5.4789 | $4.9973 | $5.2289 | +35.95% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2029
The 2029 price forecast for Vanda Pharmaceuticals Inc Stock (VNDA) is $4.0308 on average, with a high prediction of $5.9357 and a low estimate of $2.1258. This represents an +0.02% increase from the previous price of $4.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.6498 | $5.5976 | $5.3898 | +40.19% |
| February, 2029 | $6.0985 | $5.4141 | $5.9185 | +51.33% |
| March, 2029 | $5.7372 | $5.7372 | $5.9357 | +42.36% |
| April, 2029 | $5.4582 | $5.266 | $5.4094 | +35.44% |
| May, 2029 | $5.5269 | $5.5469 | $5.4103 | +37.14% |
| June, 2029 | $4.5356 | $4.6056 | $4.7091 | +12.55% |
| July, 2029 | $4.7065 | $4.4978 | $4.8743 | +16.79% |
| August, 2029 | $4.0453 | $4.2353 | $3.9109 | +0.38% |
| September, 2029 | $3.034 | $3.5541 | $3.7775 | -24.71% |
| October, 2029 | $2.2049 | $2.5527 | $3.2184 | -45.29% |
| November, 2029 | $2.0636 | $2.4236 | $2.4593 | -48.79% |
| December, 2029 | $2.7846 | $2.1258 | $2.7346 | -30.90% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2030
Vanda Pharmaceuticals Inc Stock (VNDA) is expected to reach an average price of $2.18 in 2030, with a high forecast of $3.0142 and a low forecast of $1.3459. This signifies an -45.90% decrease from the last price of $4.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7333 | $2.7389 | $2.6833 | -32.18% |
| February, 2030 | $3.052 | $3.1098 | $2.9898 | -24.27% |
| March, 2030 | $2.8807 | $2.9314 | $3.0142 | -28.52% |
| April, 2030 | $2.1917 | $2.4617 | $2.7829 | -45.62% |
| May, 2030 | $2.3804 | $2.5638 | $2.3982 | -40.93% |
| June, 2030 | $2.6791 | $2.3248 | $2.4391 | -33.52% |
| July, 2030 | $2.42 | $2.5066 | $2.4513 | -39.95% |
| August, 2030 | $1.9288 | $1.9488 | $1.9122 | -52.14% |
| September, 2030 | $2.1797 | $2.091 | $2.2925 | -45.91% |
| October, 2030 | $2.4084 | $1.9812 | $1.9819 | -40.24% |
| November, 2030 | $1.5972 | $1.945 | $2.0811 | -60.37% |
| December, 2030 | $1.0481 | $1.3459 | $1.5015 | -73.99% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):